REQUEST A DEMO
Total
USD $0.00
Search more companies

Shenzhen Hepalink Pharmaceutical Group Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shenzhen Hepalink Pharmaceutical Group Co.,Ltd Profile Updated: April 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shenzhen Hepalink Pharmaceutical Co., Ltd., has been focusing on the production of heparin products injectable grade since 1986, strictly performing in accordance with cGMP regulations. Series of products include heparin sodium and heparin calcium. The company is advantaged by its cutting-edge purification technologies and a stable supply of mucosa from healthy pigs. With the high quality products, the reliable traceability to the very starting material and the excellence in service, Hepalink has been a long-term heparin supplier of many worldly renowned pharmaceutical companies.

Headquarters
No. 21, Langshan Road, Songping Mountain, Nanshan District, Shenzhen, Guangdong Province
Shenzhen; Guangdong; Postal Code: 518057

Contact Details: Purchase the Shenzhen Hepalink Pharmaceutical Group Co.,Ltd report to view the information.

Website: http://www.hepalink.com

Basic Information
Total Employees:
Purchase the Shenzhen Hepalink Pharmaceutical Group Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Shenzhen Hepalink Pharmaceutical Group Co.,Ltd report to view the information.
Registered Capital:
Purchase the Shenzhen Hepalink Pharmaceutical Group Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Shenzhen Hepalink Pharmaceutical Group Co.,Ltd report to view the information.
Incorporation Date:
April 21, 1998
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
32.31%
Purchase this report to view the information.
27.81%
Purchase this report to view the information.
15%
Purchase this report to view the information.
3.16%
Purchase this report to view the information.
2.75%
Subsidiaries
Cytovance Biologics,Inc
100%
Cytovance Cayman,Inc.
100%
Hai Purui (Hong Kong) Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Shenzhen Hepalink Pharmaceutical Group Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
5.55%
Total operating revenue
3.17%
Operating profit (EBIT)
167.28%
EBITDA
182.46%
Net Profit (Loss) for the Period
134.42%
Total assets
-8.48%
Total equity
-2.67%
Operating Profit Margin (ROS)
8.67%
Net Profit Margin
6.19%
Return on Equity (ROE)
0.74%
Debt to Equity Ratio
-12.23%
Quick Ratio
-0.06%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?